{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:39:15Z","timestamp":1761183555954,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21mk0101189"],"award-info":[{"award-number":["JP21mk0101189"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K16505","20K16136"],"award-info":[{"award-number":["19K16505","20K16136"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jphs.2022.01.011","type":"journal-article","created":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T09:52:19Z","timestamp":1642931539000},"page":"343-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of clinically-reported, memantine-induced cardiovascular adverse responses using the halothane-anesthetized dogs: Reverse translational study"],"prefix":"10.1016","volume":"148","author":[{"given":"Ryuichi","family":"Kambayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Hagiwara-Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Izumi-Nakaseko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2022.01.011_bib1","series-title":"Basic & clinical pharmacology","first-page":"381","article-title":"Introduction to the pharmacology of CNS drugs","author":"Gray","year":"2021"},{"key":"10.1016\/j.jphs.2022.01.011_bib2","series-title":"Basic & clinical pharmacology","first-page":"1100","article-title":"Special aspects of geriatric pharmacology","author":"Katzung","year":"2021"},{"key":"10.1016\/j.jphs.2022.01.011_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jphs.2022.01.011_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-148-5-200803040-00009","article-title":"Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline","volume":"148","author":"Raina","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jphs.2022.01.011_bib5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2165\/11201020-000000000-00000","article-title":"Memantine: a review of its use in moderate to severe Alzheimer's disease","volume":"23","author":"McKeage","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jphs.2022.01.011_bib6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0269881110387547","article-title":"Dementia Consensus Group. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology","volume":"25","author":"O'Brien","year":"2011","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jphs.2022.01.011_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/gps.2384","article-title":"A\u00a0review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors","volume":"25","author":"Jones","year":"2010","journal-title":"Int J Geriatr Psychiatr"},{"key":"10.1016\/j.jphs.2022.01.011_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jcgg.2016.01.002","article-title":"Risk factors for cardiovascular events of antidementia drugs in Alzheimer's disease patients","volume":"7","author":"Hernandez","year":"2016","journal-title":"J\u00a0Clin Gerontol Geriatr"},{"key":"10.1016\/j.jphs.2022.01.011_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1533317515622283","article-title":"Toxicological differences between NMDA receptor antagonists and cholinesterase inhibitors","volume":"31","author":"Shi","year":"2016","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.jphs.2022.01.011_bib10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/pds.1620","article-title":"Does memantine induce bradycardia? A study in the French PharmacoVigilance Database","volume":"17","author":"Gallini","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jphs.2022.01.011_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/pnp.489","article-title":"Memantine-induced bradycardia - a rare adverse reaction","volume":"22","author":"Mousalidis","year":"2018","journal-title":"Prog Neurol Psychiatr"},{"key":"10.1016\/j.jphs.2022.01.011_bib12","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1111\/j.1532-5415.2012.04241.x","article-title":"Comparative cardiovascular safety of dementia medications: a cross-national study","volume":"60","author":"Fosb\u00f8l","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jphs.2022.01.011_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/pcn.12236","article-title":"QT prolongation associated with memantine in Alzheimer's disease","volume":"69","author":"Takehara","year":"2015","journal-title":"Psychiatr Clin Neurosci"},{"key":"10.1016\/j.jphs.2022.01.011_bib14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/FJC.0000000000000424","article-title":"Cardiac N-methyl D-aspartate receptors as a pharmacological target","volume":"68","author":"Makhro","year":"2016","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jphs.2022.01.011_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0014-2999(98)00914-5","article-title":"Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists","volume":"366","author":"D'Amico","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2022.01.011_bib16","first-page":"1237","article-title":"Activation of N-methyl-d-aspartate receptors reduces heart rate variability and facilitates atrial fibrillation in rats","volume":"19","author":"Shi","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jphs.2022.01.011_bib17","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1139\/cjpp-2017-0056","article-title":"Modulation of N-methyl-d-aspartate receptors in isolated rat heart","volume":"95","author":"Srejovic","year":"2017","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jphs.2022.01.011_bib18","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.biopha.2018.09.153","article-title":"Memantine, an NMDA receptor antagonist, attenuates cardiac remodeling, lipid peroxidation and neutrophil recruitment in heart failure: a cardioprotective agent?","volume":"108","author":"Abbaszadeh","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jphs.2022.01.011_bib19","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/bjp.2008.240","article-title":"Sensitive and reliable proarrhythmia in\u00a0vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts","volume":"154","author":"Sugiyama","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2022.01.011_bib20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1254\/jjp.88.414","article-title":"Effects of a typical IKr channel blocker sematilide on the relationship between ventricular repolarization, refractoriness and onset of torsades de pointes","volume":"88","author":"Sugiyama","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.jphs.2022.01.011_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/clpt.2014.155","article-title":"Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil","volume":"96","author":"Johannesen","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jphs.2022.01.011_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00210-020-01997-w","article-title":"Analysis of electropharmacological and proarrhythmic effects of donepezil using the halothane-anesthetized intact dogs and the conscious chronic atrioventricular block ones","volume":"394","author":"Hagiwara-Nagasawa","year":"2020","journal-title":"Naunyn Schmiedeberg Arch Pharmacol"},{"key":"10.1016\/j.jphs.2022.01.011_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0735-1097(00)01056-1","article-title":"Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler","volume":"37","author":"Nagueh","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jphs.2022.01.011_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0160-5402(89)90015-6","article-title":"An improved method to correct the QT interval of the electrocardiogram for changes in heart rate","volume":"22","author":"Van de Water","year":"1989","journal-title":"J\u00a0Pharmacol Methods"},{"key":"10.1016\/j.jphs.2022.01.011_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/FJC.0000000000000398","article-title":"N-methyl-D-aspartate receptor signaling and function in cardiovascular tissues","volume":"68","author":"McGee","year":"2016","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jphs.2022.01.011_bib26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/mol.53.3.555","article-title":"Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor","volume":"53","author":"Buisson","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jphs.2022.01.011_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/157015908783769671","article-title":"Pharmacodynamics of memantine: an update","volume":"6","author":"Rammes","year":"2008","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.jphs.2022.01.011_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(01)01872-9","article-title":"The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2\/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner","volume":"306","author":"Rammes","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jphs.2022.01.011_bib29","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1471-4159.2006.03991.x","article-title":"The chemical biology of clinically tolerated NMDA receptor antagonists","volume":"97","author":"Chen","year":"2006","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.jphs.2022.01.011_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/syn.20472","article-title":"Memantine agonist action at dopamine D2High receptors","volume":"62","author":"Seeman","year":"2008","journal-title":"Synapse"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:01:52Z","timestamp":1761163312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861322000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1347861322000111"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2022.01.011","relation":{},"ISSN":["1347-8613"],"issn-type":[{"type":"print","value":"1347-8613"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of clinically-reported, memantine-induced cardiovascular adverse responses using the halothane-anesthetized dogs: Reverse translational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2022.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}